Objective Daytime Napping is Associated with Disease Severity and Inflammation in Patients with Mild to Moderate Dementia1

J Alzheimers Dis. 2020;74(3):803-815. doi: 10.3233/JAD-190483.

Abstract

Background: Patients with dementia report excessive daytime sleep/sleepiness, which is associated with worse cognitive performance. Inflammatory markers may be elevated in patients with dementia and have been proposed as mediators of sleep/sleepiness.

Objective: To examine the association of objective daytime napping with cognitive performance and peripheral markers of inflammation in patients with dementia as compared to not cognitively impaired (NCI) controls.

Methods: A sub-sample of 46 patients with mild-to-moderate dementia and 85 NCI controls, were recruited from a large, population-based cohort of 3,140 elders (≥60 years) in Crete, Greece. All participants underwent medical history/physical examination, extensive neuropsychiatric and neuropsychological evaluation, 3-day 24 h actigraphy and a single morning measure of IL-6 and TNFα plasma levels. Comparisons of sleep parameters and inflammation markers between diagnostic groups, and between nappers and non-nappers within each diagnostic group, were conducted using ANCOVA controlling for demographics/related clinical factors. Associations between inflammatory markers, sleep variables, and neuropsychological performance were assessed within each group using partial correlation analysis controlling for confounders.

Results: Patients with dementia slept 15 minutes longer during the day than NCI. Within dementia patients, nappers had significantly worse performance on autobiographic memory (p = 0.002), working memory (p = 0.007), episodic memory (p = 0.010), and assessment of daily function (p = 0.012) than non-nappers. Finally, IL-6 levels were significantly associated with nap duration within dementia patients who napped (r = 0.500, p = 0.01).

Conclusions: Daytime napping in patients with dementia is associated with worse cognitive performance and increased IL-6 levels. In dementia, objective daytime napping, may be a marker of the severity of the disease.

Keywords: Actigraphy; cognitive performance; cytokines; dementia; inflammation; objective daytime napping.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actigraphy
  • Activities of Daily Living / psychology
  • Aged
  • Aged, 80 and over
  • Cognition
  • Cohort Studies
  • Dementia / pathology*
  • Dementia / psychology*
  • Encephalitis / pathology*
  • Female
  • Humans
  • Interleukin-6 / blood
  • Male
  • Memory
  • Mental Status and Dementia Tests
  • Middle Aged
  • Neuropsychological Tests
  • Psychomotor Performance
  • Sleep*
  • Tumor Necrosis Factor-alpha / blood

Substances

  • IL6 protein, human
  • Interleukin-6
  • Tumor Necrosis Factor-alpha